|
2025
|
Invention
|
Antigen binding proteins.
Antigen binding proteins of the invention bind to Human Immunodeficien... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication.
A compound of Formula (1), including pha... |
|
2024
|
Invention
|
Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication.
T... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication.
Compounds and pharmaceutically acceptabl... |
|
2022
|
Invention
|
C-3 and c-17 modified triterpenoids as hiv-1 inhibitors.
Compounds having drug and bio-affecting... |
|
2021
|
Invention
|
Inhibitors of human immunodeficiency virus replication.
A pharmaceutical composition comprising ... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication.
Compounds of Formula I, including pharma... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication.
A compound of Formula I, including pharm... |
|
2020
|
Invention
|
Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication. T... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication.
The compounds depicted below, and pharma... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication.
The compound
The compound
The co... |
|
2019
|
Invention
|
Inhibitors of human immunodeficiency virus replication.
Compounds of Formula I, and pharmaceutic... |
|
|
Invention
|
Quinazolinyl-indazole derivatives and their use as inhibitors of human immunodeficiency virus rep... |
|
|
Invention
|
Inhibitors of human immunodeficiency virus replication. Compounds of Formula I, including pharmac... |
|
|
Invention
|
C-3 and c-17 modified triterpenoids as hiv-1 inhibitors. Compounds having drug and bio-affecting ... |
|
|
Invention
|
Compounds with hiv maturation inhibitory activity.
The present invention relates to compound of ... |
|
|
Invention
|
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication.... |
|
2018
|
Invention
|
Antigen binding polypeptides.
The invention is directed to an antigen binding polypeptide compri... |
|
|
Invention
|
5-(n-benzyl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of hum... |
|
2017
|
Invention
|
Aza-substituted inhibitors of human immunodeficiency virus replication.
Compounds having drug an... |
|
|
Invention
|
Azadecalin derivatives as inhibitors of human immunodeficiency virus replication. Compounds havin... |
|
|
Invention
|
Triterpenoid inhibitors of human immunodeficiency virus replication.
Compounds having drug and b... |
|
|
Invention
|
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication.
... |
|
|
Invention
|
Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication. D... |
|
|
Invention
|
Fostemsavir for use in heavily treatment-experienced hiv-1 infected individuals.
A method of att... |
|
2016
|
Invention
|
Imidazopyridine macrocycles as inhibitors of human immunodeficiency virus replication. Disclosed ... |
|
|
Invention
|
Substituted pyridines as inhibitors of human immunodeficiency virus replication. 1 is phenyl subs... |
|
|
Invention
|
5-(n-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inh... |
|
2015
|
Invention
|
Imidazo[1,2-a]pyridine derivatives for use as inhibitors of human immunodeficiency virus replicat... |
